Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17011-17019
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17011
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17011
MicroRNAs | Dysregulation | Clinical phenotypes | Ref. |
miR-221 | Upregulated in CRC | Prognostic factors for poor overall survival in CRC patients | [90] |
miR-141 | Upregulated in CRC | Higher level associated with poor survival; an independent prognostic factor for advanced CRC | [71] |
pre-miR-423 | Upregulated in CRC | SNPs in these miRNAs were significantly associated with recurrence-free survival in CRC | [91] |
pre-miR-608 | Upregulated in CRC | [91] | |
miR-222 | Upregulated in CRC | Played a role in the development of MDR by modulation of ADAM-17 in CRC | [79,92] |
miR-328 | Upregulated in CRC | Chemotherapeutic insensitive CRC cells, carrying stem cell-like properties, could be reversed by restoring miR-328 to normal | [79] |
let-7g | Upregulated in CRC | Higher level associated with poor S-1 response; was prognostic in early-stage CRC | [10,93] |
miR-18a | Upregulated in CRC | Higher level associated with poor overall survival | [94] |
miR-21 | Upregulated in adenoma, CRC, and liver metastases | Higher level associated with lymph node metastasis, poor survival, poor therapeutic outcomes, rapid recurrence, and shorter disease-free interval | [88] |
miR-31 | Upregulated in CRC | Higher level associated with higher TNM stages and local invasion | [91] |
miR-106a | Upregulated in colon cancer | Higher level associated with longer disease-free survival and overall survival | [10] |
miR-143 | Downregulated in colon cancer and liver metastases | Lower level associated with larger tumour size and longer disease-free interval; expression levels served as an independent prognostic biomarker for KRAS wild-type CRC | [65,91] |
miR-145 | Downregulated in CRC | Lower level associated with large tumour size and tumour location | [65,91] |
miR-181b | Upregulated in CRC | Higher level associated with poor S-1 response | [10] |
miR-320 | Downregulated in MSS tumour | Lower level associated with shorter progression-free survival | [94] |
miR-498 | Downregulated in MSS tumour | Lower level associated with shorter progression-free survival | [94] |
- Citation: Muhammad S, Kaur K, Huang R, Zhang Q, Kaur P, Yazdani HO, Bilal MU, Zheng J, Zheng L, Wang XS. MicroRNAs in colorectal cancer: Role in metastasis and clinical perspectives. World J Gastroenterol 2014; 20(45): 17011-17019
- URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17011.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17011